Ozempic-Maker Novo Nordisk Accuses Eli Lilly of False Advertising

Novo Nordisk, the maker of Ozempic, has initiated legal action against rival pharmaceutical company Eli Lilly, alleging that its advertisements are misleading, a claim Eli Lilly denies.